Thomas C. Harding Clovis Oncology, Inc. (CLVS) insider trading activity

Thomas C. Harding is Officer of Clovis Oncology, Inc.. Currently has a direct ownership of 19,487 shares of CLVS, which is worth approximately $1,753. The most recent transaction as insider was on Nov 02, 2022, when has been sold 1,703 shares (Common Stock) at a price of $0.98 per share, resulting in proceeds of $1,668. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.5K

0% 3M change

0% 12M change

Total Value Held $1,753

Thomas C. Harding Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 02 2022	SELL Open market or private sale	$1,668 $0.98 p/Share	1,703 Reduced 8.04%	19,487 Common Stock
Nov 01 2022	BUY Exercise of conversion of derivative security	-	3,374 Added 14.19%	20,402 Common Stock
Sep 02 2022	SELL Open market or private sale	$1,733 $1.2 p/Share	1,444 Reduced 7.5%	17,816 Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	-	2,896 Added 13.07%	19,260 Common Stock
Aug 02 2022	SELL Open market or private sale	$2,529 $1.46 p/Share	1,732 Reduced 9.57%	16,364 Common Stock
Aug 01 2022	BUY Exercise of conversion of derivative security	-	3,376 Added 16.33%	17,294 Common Stock
Jun 02 2022	SELL Open market or private sale	$963 $0.64 p/Share	1,504 Reduced 9.27%	14,720 Common Stock
Jun 01 2022	BUY Exercise of conversion of derivative security	-	2,896 Added 15.15%	16,224 Common Stock
May 02 2022	SELL Open market or private sale	$3,349 $1.97 p/Share	1,700 Reduced 11.31%	13,328 Common Stock
May 01 2022	BUY Exercise of conversion of derivative security	-	3,374 Added 19.15%	14,241 Common Stock
Mar 02 2022	SELL Open market or private sale	$12,989 $1.87 p/Share	6,946 Reduced 37.34%	11,654 Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	-	11,866 Added 39.16%	18,434 Common Stock
Feb 02 2022	SELL Open market or private sale	$3,952 $1.94 p/Share	2,037 Reduced 23.22%	6,734 Common Stock
Feb 01 2022	BUY Exercise of conversion of derivative security	-	3,376 Added 30.13%	7,828 Common Stock
Dec 02 2021	SELL Open market or private sale	$423 $3.0 p/Share	141 Reduced 2.55%	5,395 Common Stock
Dec 01 2021	BUY Exercise of conversion of derivative security	-	281 Added 4.83%	5,536 Common Stock
Nov 02 2021	SELL Open market or private sale	$7,653 $4.55 p/Share	1,682 Reduced 24.25%	5,255 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	-	3,374 Added 35.4%	6,158 Common Stock
Sep 02 2021	SELL Open market or private sale	$689 $4.89 p/Share	141 Reduced 3.81%	3,563 Common Stock
Sep 01 2021	BUY Exercise of conversion of derivative security	-	281 Added 7.05%	3,704 Common Stock
Aug 03 2021	SELL Open market or private sale	$8,088 $4.82 p/Share	1,678 Reduced 32.9%	3,423 Common Stock
Aug 01 2021	BUY Exercise of conversion of derivative security	-	3,376 Added 43.84%	4,324 Common Stock
Jun 03 2021	SELL Open market or private sale	$738 $5.63 p/Share	131 Reduced 7.06%	1,725 Common Stock
Jun 01 2021	BUY Exercise of conversion of derivative security	-	281 Added 13.15%	1,856 Common Stock
May 04 2021	SELL Open market or private sale	$9,966 $5.54 p/Share	1,799 Reduced 53.32%	1,575 Common Stock

TCH

Thomas C. Harding

Officer

Boulder, CO

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLVS shares.

Notify only if

Value

Insider Trading

Get notified when an Clovis Oncology, Inc. insider buys or sells CLVS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Clovis Oncology, Inc.

Track Activities on CLVS

Account